A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Genital Chlamydia trachomatis (Ct) infection induces protective immunity that depends on interferon-γ-producing CD4 T cells. By contrast, we report that mucosal exposure to ultraviolet light (UV)-inactivated Ct (UV-Ct) generated regulatory T cells that exacerbated subsequent Ct infection. We show that mucosal immunization with UV-Ct complexed with charge-switching synthetic adjuvant particles (cSAPs) elicited long-lived protection in conventional and humanized mice. UV-Ct-cSAP targeted immunogenic uterine CD11b(+)CD103(-) dendritic cells (DCs), whereas UV-Ct accumulated in tolerogenic CD11b(-)CD103(+) DCs. Regardless of vaccination route, UV-Ct-cSAP induced systemic memory T cells, but only mucosal vaccination induced effector T cells that rapidly seeded uterine mucosa with resident memory T cells (T(RM) cells). Optimal Ct clearance required both T(RM) seeding and subsequent infection-induced recruitment of circulating memory T cells. Thus, UV-Ct-cSAP vaccination generated two synergistic memory T cell subsets with distinct migratory properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“B and T cells, including Tregs and Th17 cells can, upon being primed by DCs presenting antigen derived from commensal organisms in draining mLNs of the gut, circulate systemically to facilitate immune responses at distant sites”
From The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy (2018) · cites this paper as Stary et al., 2015
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 1×
“For some experiments, we crossed NR1 and Foxp3eGFP mice (62).”
MethodTwo subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846 · cited 1×
“This systemic memory population, which comprises the two classical central and effector memory subsets (59), does not appear to access the resting urogenital mucosa but can be recruited to peripheral tissues (including uterine mucosa) upon the onset of inflammation (60).”
BackgroundJung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632 · cited 1×
“For characterization of uterine APC subsets, CXCR3 mice (63) were used.”
MethodT-Cell Function and Migration — Two Sides of the Same Coin
von Andrian, U. H., & Mackay, C. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010053431407 · Cited by 1,437 · cited 3×
“It is likely that additional trafficking molecules, such as chemokines, are involved in a tissue-specific multistep adhesion cascade for T cell recruitment to normal uterine mucosa (53), but the molecular identity of these constitutive traffic signals remains to be determined.”
BackgroundInfluentialSexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008
Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., Ocfemia, M. C. B., Su, J., Xu, F., & Weinstock, H. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318286bb53 · Cited by 1,260
Gebhardt, T., Wakim, L. M., Eidsmo, L., Reading, P. C., Heath, W. R., & Carbone, F. R. (2009) · Nature Immunology · doi:10.1038/ni.1718 · Cited by 1,157 · cited 1×
“Acquisition of tissue tropism enables the preferential migration of Ag-experienced lymphocytes to regions of the body that are associated with the secondary lymphoid organs where Ag was first encountered (2, 3, 5-11).”
BackgroundSelective imprinting of gut-homing T cells by Peyer's patch dendritic cells
Mora, J. R., Bono, M. R., Manjunath, N., Weninger, W., Cavanagh, L. L., Rosemblatt, M., & von Andrian, U. H. (2003) · Nature · doi:10.1038/nature01726 · Cited by 1,074 · cited 3×
“Although systemic memory cells were elicited by all immunization routes, their protective capacity may vary due to differential imprinting of mucosal homing pathways during the priming phase (2-4, 54, 55).”
BackgroundGeneration of Gut-Homing IgA-Secreting B Cells by Intestinal Dendritic Cells
Mora, J. R., Iwata, M., Eksteen, B., Song, S.-Y., Junt, T., Senman, B., Otipoby, K. L., Yokota, A., Takeuchi, H., Ricciardi-Castagnoli, P., et al. (2006) · Science · doi:10.1126/science.1132742 · Cited by 1,011 · cited 1×
“, Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion.”
BackgroundGoblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine
McDole, J. R., Wheeler, L. W., McDonald, K. G., Wang, B., Konjufca, V., Knoop, K. A., Newberry, R. D., & Miller, M. J. (2012) · Nature · doi:10.1038/nature10863 · Cited by 976
Physiological Migration of Hematopoietic Stem and Progenitor Cells
Wright, D. E., Wagers, A. J., Gulati, A. P., Johnson, F. L., & Weissman, I. L. (2001) · Science · doi:10.1126/science.1064081 · Cited by 933 · cited 1×
“Parabiosis surgery was performed as previously described (55).”
Method
Cited by
The microbiota in adaptive immune homeostasis and disease
Honda, K., & Littman, D. R. (2016) · Nature · doi:10.1038/nature18848 · Cited by 1,846
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
Gopalakrishnan, V., Helmink, B. A., Spencer, C. N., Reuben, A., & Wargo, J. A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.015 · Cited by 1,392
“…cells, can, upon being primed by DCs presenting antigen derived from commensal organisms in draining mLNs of the gut, circulate systemically to facilitate immune responses at distant sites against the same organism or against other antigens by crossreaction to similar epitopes (Stary et al., 2015).”
BackgroundTissue-resident memory T cells: local specialists in immune defence
Mueller, S. N., & Mackay, L. K. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.3 · Cited by 1,006
The multifaceted role of CD4+ T cells in CD8+ T cell memory
Laidlaw, B. J., Craft, J. E., & Kaech, S. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.10 · Cited by 657
Tissue-Resident T Cells and Other Resident Leukocytes
Masopust, D., & Soerens, A. G. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053214 · Cited by 608
“That said, local antigen recognition can have a pronounced influence on the differentiation of Trm cells, and in situ detection during the effector phase of the immune response promotes Trm cell accumulation in certain tissues including brain, skin, lung, and the female reproductive tract (37, 47, 90, 99, 101, 102).”
BackgroundHumanized Mouse Models of Clinical Disease
Walsh, N. C., Kenney, L. L., Jangalwe, S., Aryee, K.-E., Greiner, D. L., Brehm, M. A., & Shultz, L. D. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100332 · Cited by 562
Gerlach, C., Moseman, E. A., Loughhead, S. M., Alvarez, D., Zwijnenburg, A. J., Waanders, L., Garg, R., de la Torre, J. C., & von Andrian, U. H. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.018 · Cited by 567
“This tissueconfined, non-migratory Tmem population is derived from Teff cells that seed non-lymphoid tissues early after infection (Mackay et al., 2013; Masopust et al., 2010; Stary et al., 2015).”
BackgroundDendritic cell migration in inflammation and immunity
Liu, J., Zhang, X., Cheng, Y., & Cao, X. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00726-4 · Cited by 537
Understanding subset diversity in T cell memory
Jameson, S. C., & Masopust, D. (2018) · Immunity · doi:10.1016/j.immuni.2018.02.010 · Cited by 523
“…hastening clearance of viral, bacterial, and parasitic infections in mucosal tissues, skin, and even solid organs (Gebhardt et al., 2009; Glennie et al., 2015; Iijima and Iwasaki, 2014; Jiang et al., 2012; Schenkel et al., 2014a; Schenkel et al., 2013; Shin and Iwasaki, 2012; Stary et al., 2015).”
Zens, K. D., Chen, J. K., & Farber, D. L. (2016) · JCI Insight · doi:10.1172/jci.insight.85832 · Cited by 418
Hallmarks of Tissue-Resident Lymphocytes
Fan, X., & Rudensky, A. Y. (2016) · Cell · doi:10.1016/j.cell.2016.02.048 · Cited by 354
“TRM cells seed tissues early during the immune response to infection and represent a subset distinct from recirculating memory T cells in blood and secondary lymphoid organs (Clark, 2015; Schenkel and Masopust, 2014; Stary et al., 2015).”
BackgroundSharma, C., Rokana, N., Chandra, M., Singh, B. P., Gulhane, R. D., Gill, J. P. S., Ray, P., Puniya, A. K., & Panwar, H. (2018) · Frontiers in Veterinary Science · doi:10.3389/fvets.2017.00237 · Cited by 308
Künzli, M., & Masopust, D. (2023) · Nature Immunology · doi:10.1038/s41590-023-01510-4 · Cited by 338
Biomimetic Nanotechnology toward Personalized Vaccines
Zhou, J., Kroll, A. V., Holay, M., Fang, R. H., & Zhang, L. (2020) · Advanced Materials · doi:10.1002/adma.201901255 · Cited by 328
Induction of resident memory T cells enhances the efficacy of cancer vaccine
Nizard, M., Roussel, H., Diniz, M. O., Karaki, S., Tran, T., Voron, T., Dransart, E., Sandoval, F., Riquet, M., Rance, B., et al. (2017) · Nature Communications · doi:10.1038/ncomms15221 · Cited by 308
Tissue-resident memory T cells at the center of immunity to solid tumors
Amsen, D., van Gisbergen, K. P. J. M., Hombrink, P., & van Lier, R. A. W. (2018) · Nature Immunology · doi:10.1038/s41590-018-0114-2 · Cited by 278
Gut microbiome and cancer immunotherapy
Li, W., Deng, Y., Chu, Q., & Zhang, P. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.015 · Cited by 253
Beura, L. K., Mitchell, J. S., Thompson, E. A., Schenkel, J. M., Mohammed, J., Wijeyesinghe, S., Fonseca, R., Burbach, B. J., Hickman, H. D., Vezys, V., et al. (2018) · Nature Immunology · doi:10.1038/s41590-017-0029-3 · Cited by 256
Nanomedicines for renal disease: current status and future applications
Kamaly, N., He, J. C., Ausiello, D. A., & Farokhzad, O. C. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.156 · Cited by 250
Self-citationPerdomo, C., Zedler, U., Kühl, A. A., Lozza, L., Saikali, P., Sander, L. E., Vogelzang, A., Kaufmann, S. H. E., & Kupz, A. (2016) · mBio · doi:10.1128/mbio.01686-16 · Cited by 254
Memory CD4+ T Cells in Immunity and Autoimmune Diseases
Raphael, I., Joern, R. R., & Forsthuber, T. G. (2020) · Cells · doi:10.3390/cells9030531 · Cited by 230
Chlamydia trachomatis Genital Infections
O’Connell, C. M., & Ferone, M. E. (2016) · Microbial Cell · doi:10.15698/mic2016.09.525 · Cited by 213
Tissue‐resident memory T cells in tissue homeostasis, persistent infection, and cancer surveillance
Gebhardt, T., Palendira, U., Tscharke, D. C., & Bedoui, S. (2018) · Immunological Reviews · doi:10.1111/imr.12650 · Cited by 200
Brix, N., Tiefenthaller, A., Anders, H., Belka, C., & Lauber, K. (2017) · Immunological Reviews · doi:10.1111/imr.12573 · Cited by 197
Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery
Gause, K. T., Wheatley, A. K., Cui, J., Yan, Y., Kent, S. J., & Caruso, F. (2017) · ACS Nano · doi:10.1021/acsnano.6b07343 · Cited by 196
Immunological memory: lessons from the past and a look to the future
Farber, D. L., Netea, M. G., Radbruch, A., Rajewsky, K., & Zinkernagel, R. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.13 · Cited by 200
Roquilly, A., McWilliam, H. E. G., Jacqueline, C., Tian, Z., Cinotti, R., Rimbert, M., Wakim, L., Caminschi, I., Lahoud, M. H., Belz, G. T., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.021 · Cited by 186
Shields, C. W., Wang, L. L., Evans, M. A., & Mitragotri, S. (2020) · Advanced Materials · doi:10.1002/adma.201901633 · Cited by 193
CD4+ resident memory T cells dominate immunosurveillance and orchestrate local recall responses
Beura, L. K., Fares-Frederickson, N. J., Steinert, E. M., Scott, M. C., Thompson, E. A., Fraser, K. A., Schenkel, J. M., Vezys, V., & Masopust, D. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181365 · Cited by 190
“However, firm evidence for CD4+ TRM in the reproductive mucosa has been reported (Iijima and Iwasaki, 2014; Stary et al., 2015).”
BackgroundImproving Vaccine and Immunotherapy Design Using Biomaterials
Bookstaver, M. L., Tsai, S. J., Bromberg, J. S., & Jewell, C. M. (2018) · Trends in Immunology · doi:10.1016/j.it.2017.10.002 · Cited by 183
“Poly(D,L-lactic-co-glycolic acid)-bpoly(L-histidine)-b-poly(ethylene glycol) Particulate delivery of antigen can change the immune response from tolerogenic to long-lived protection [49]”
Polymeric nanoparticle vaccines to combat emerging and pandemic threats
Wibowo, D., Jorritsma, S. H. T., Gonzaga, Z. J., Evert, B., Chen, S., & Rehm, B. H. A. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120597 · Cited by 174
Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation
Chattopadhyay, S., Chen, J.-Y., Chen, H.-W., & Hu, C.-M. J. (2017) · Nanotheranostics · doi:10.7150/ntno.19796 · Cited by 166
“Adjuvants have also been encapsulated or chemically attached to the PLGA polymer backbone for controlled delivery to enhance immune responses [69-72].”
BackgroundAmezcua Vesely, M. C., Pallis, P., Bielecki, P., Low, J. S., Zhao, J., Harman, C. C. D., Kroehling, L., Jackson, R., Bailis, W., Licona-Limón, P., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.032 · Cited by 173
Kang, S., Ahn, S., Lee, J., Kim, J. Y., Choi, M., Gujrati, V., Kim, H., Kim, J., Shin, E.-C., & Jon, S. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.024 · Cited by 159
Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in Women
Menon, S., Timms, P., ALLAN, J. A. B., Alexander, K. E., Rombauts, L. J. F., Horner, P., Keltz, M. D., Hocking, J. S., & Huston, W. M. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00035-15 · Cited by 155
Modulating the immune system through nanotechnology
Dacoba, T. G., Ana, O., Torres, D., Crecente‐Campo, J., & Alonso, M. J. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.007 · Cited by 160
Pathophysiology of Skin Resident Memory T Cells
Tokura, Y., Phadungsaksawasdi, P., Kurihara, K., Fujiyama, T., & Honda, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.618897 · Cited by 140
“org 3 (34), Chlamydia trachomatis infection at the reproductive mucosa (49), and Streptococcus pneumonia infection in the lung (50).”
BackgroundNiches for the Long-Term Maintenance of Tissue-Resident Memory T Cells
Takamura, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01214 · Cited by 151
Gottlieb, S. L., Deal, C. D., Giersing, B. K., Rees, H., BOLAN, G. A., Johnston, C., Timms, P., Gray‐Owen, S. D., Jerse, A. E., Cameron, C. E., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.111 · Cited by 139
Darville, T. L. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab031 · Cited by 128
Distinct functions of tissue-resident and circulating memory Th2 cells in allergic airway disease
Rahimi, R. A., Nepal, K., Çetinbaş, M., Sadreyev, R. I., & Luster, A. D. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190865 · Cited by 135
Update on Chlamydia trachomatis Vaccinology
de la Maza, L. M., Zhong, G., & Brunham, R. C. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00543-16 · Cited by 122
“(85) supports enhanced protection using a mucosal route for immunization.”
BackgroundStrobl, J., Pandey, R. V., Krausgruber, T., Bayer, N., Kleißl, L., Reininger, B., Vieyra-Garcia, P. A., Wolf, P., Jentus, M. M., Mitterbauer, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abb7028 · Cited by 123
“Different experimental approaches have verified tissue residency of T cells, including (i) parabiosis, in which mice are surgically conjoined and Trm can be identified by genetic markers in the two partner mice (1, 3); (ii) mixed bone marrow chimeras, in which mice are lethally irradiated and reconstituted with bone m…”
BackgroundSelf-citationThe Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases
Yang, X., Lu, D., Zhuo, J., Lin, Z., Yang, M., & Xu, X. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.46405 · Cited by 119
Qin, L., Zhang, H., Zhou, Y., Umeshappa, C. S., & Gao, H. (2021) · Small · doi:10.1002/smll.202006000 · Cited by 115
Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity
Molodtsov, A., & Turk, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02810 · Cited by 106
Lin, L. C. W., Chattopadhyay, S., Lin, J., & Hu, C. J. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701395 · Cited by 112
Traxinger, B. R., Richert-Spuhler, L. E., & Lund, J. M. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00471-x · Cited by 118
Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates
Vasilevsky, S., Stojanov, M., Greub, G., & Baud, D. (2015) · Virulence · doi:10.1080/21505594.2015.1111509 · Cited by 95
M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection
Eliasson, D. G., Omokanye, A., Schön, K., Wenzel, U. A., Bernasconi, V., Bemark, M., Kolpe, A. B., Bakkouri, K. E., Ysenbaert, T., Deng, L., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.14 · Cited by 102
Karaki, S., Blanc, C., Tran, T., Galy–Fauroux, I., Mougel, A., Dransart, E., Anson, M., Tanchot, C., Paolini, L., Gruel, N., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001948 · Cited by 101
Dendritic cells from the human female reproductive tract rapidly capture and respond to HIV
Rodríguez‐García, M., Shen, Z., Barr, F. D., Boesch, A. W., Ackerman, M. E., Kappes, J. C., Ochsenbauer, C., & Wira, C. R. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.72 · Cited by 99
Rakhra, K., Abraham, W. D., Wang, C., Moynihan, K. D., Li, N., Donahue, N. D., Baldeon, A. D., & Irvine, D. J. (2021) · Science Immunology · doi:10.1126/sciimmunol.abd8003 · Cited by 90
Organism-Level Analysis of Vaccination Reveals Networks of Protection across Tissues
Kadoki, M., Patil, A., Thaiss, C. C., Brooks, D., Pandey, S., Deep, D., Álvarez, D., von Andrian, U. H., Wagers, A. J., Nakai, K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.08.024 · Cited by 88
“However, TRM cells are typically seeded locally, at the site of pathogen entry, not systemically (Mueller and Mackay, 2016), with two exceptions of distant TRM seeding across the skin epithelia (Jiang et al., 2012) and from nasal to uterine mucosa (Stary et al., 2015).”
Modes of Action for Mucosal Vaccine Adjuvants
Aoshi, T. (2017) · Viral Immunology · doi:10.1089/vim.2017.0026 · Cited by 86
Local immunization impacts the response of dairy cows to Escherichia coli mastitis
Herry, V., Gitton, C., Tabouret, G., Répérant, M., Forge, L., Tasca, C., Gilbert, F. B., Guitton, É., Barc, C., Staub, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03724-7 · Cited by 94
CD4 TRM Cells Following Infection and Immunization: Implications for More Effective Vaccine Design
Wilk, M. M., & Mills, K. H. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01860 · Cited by 85
“showed that genital infection with C. trachomatis induced protective immunity in the uterus, whereas immunization with UV-inactivated C. trachomatis, which favored generation of regulatory T cells, exacerbated subsequent infection (53) .”
BackgroundInfluentialStolp, B., Thelen, F., Ficht, X., Altenburger, L. M., Ruef, N., Inavalli, V. V. G. K., Germann, P., Pagé, N., Moalli, F., Raimondi, A., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.aaz4371 · Cited by 85
Mucosal immunity and vaccination strategies: current insights and future perspectives
Zhang, Z., Hong, W., Zhang, Y., Li, X., Que, H., & Wei, X. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00301-7 · Cited by 85
Future prospects for new vaccines against sexually transmitted infections
Gottlieb, S. L., & Johnston, C. (2017) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000343 · Cited by 79
Intestinal Barrier Interactions with Specialized CD8 T Cells
Konjar, Š., Ferreira, C., Blankenhaus, B., & Veldhoen, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01281 · Cited by 77
Muruganandah, V., Sathkumara, H. D., Navarro, S., & Kupz, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01574 · Cited by 84
“Optimal protection against Chlamydia requires both the recruitment of TCM and the presence of TRM within the urogenital tract (158, 159).”
BackgroundStatus of vaccine research and development of vaccines for Chlamydia trachomatis infection
Poston, T. B., Gottlieb, S. L., & Darville, T. L. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.01.023 · Cited by 87
Potential Impacts of Prebiotics and Probiotics on Cancer Prevention
Samanta, S. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621999201210220442 · Cited by 82
Bakshi, R. K., Gupta, K., Jordan, S. J., Chi, X., Lensing, S., Press, C. G., & Geisler, W. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01981 · Cited by 73
“The murine model of CT infection clearly supports a Th1 IFN-γ response as necessary for eradication of primary CT infection and a correlate for protective immunity against CT reinfection upon re-exposure (12, 13, 25).”
Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens
Dotiwala, F., & Upadhyay, A. (2023) · Vaccines · doi:10.3390/vaccines11101585 · Cited by 76
“DCs activated at a mucosal immunization site also recirculate to secondary lymphoid tissues to induce T cell priming systemically and at distant mucosal tissues like the vaginal tract [74].”
BackgroundPrime and target immunization protects against liver-stage malaria in mice
Gola, A., Silman, D., Walters, A. A., Sridhar, S., Uderhardt, S., Salman, A. M., Halbroth, B. R., Bellamy, D., Bowyer, G., Powlson, J., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aap9128 · Cited by 72
Sharma, T., Gupta, A., Chauhan, R., Bhat, A. A., Nisar, S., Hashem, S., Akhtar, S., Ahmad, A., Haris, M., Singh, M., et al. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10026-6 · Cited by 74
Sensing the enemy, containing the threat: cell-autonomous immunity toChlamydia trachomatis
Finethy, R., & Coers, J. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw027 · Cited by 75
Gut Microbiome Modulates Response to Cancer Immunotherapy
Khan, M. A. W., Ologun, G. O., Arora, R., McQuade, J. L., & Wargo, J. A. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06111-x · Cited by 75
Mucosal vaccination: onward and upward
Tsai, C. J., Loh, J. M. S., Fujihashi, K., & Kiyono, H. (2023) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2268724 · Cited by 73
Wang, N., Zhen, Y., Jin, Y., Wang, X., Li, N., Jiang, S., & Wang, T. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.009 · Cited by 66
Vaccination against Salmonella Infection: the Mucosal Way
Gayet, R., Bioley, G., Rochereau, N., Paul, S., & Corthésy, B. (2017) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00007-17 · Cited by 71
“For example, mucosal delivery of charge-switching synthetic NPs containing encapsulated monophosphoryl lipid A (MPLA) and coated with inactivated Chlamydia trachomatis leads to a specific protective and long-lasting Th1 response in mice (219).”
BackgroundLijek, R. S., Helble, J. D., Olive, A. J., Seiger, K. W., & Starnbach, M. N. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711356115 · Cited by 64
Self-citationAn overview of biodegradable nanomaterials and applications in vaccines
Yan, X., Zhou, M., Yu, S., Jin, Z., & Zhao, K. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.11.031 · Cited by 69
Chlamydia trachomatisvaccines for genital infections: where are we and how far is there to go?
de la Maza, L. M., Darville, T. L., & Pal, S. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1899817 · Cited by 64
Prevention strategies for sexually transmitted infections, HIV, and viral hepatitis in Europe
Gökengin, D., Noori, T., Alemany, A., Bieńkowski, C., Liegon, G., İnkaya, A. Ç., Carrillo, J., Stary, G., Knapp, K., Mitjà, J., et al. (2023) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100738 · Cited by 73
“112 To induce strong immune responses against chlamydia at mucosal sites may require developing mucosal adjuvants and delivery systems to direct the immune response towards mucosal tissues.”
BackgroundSelf-citationPosavad, C. M., Zhao, L., Dong, L., Jin, L., Stevens, C. E., Magaret, A. S., Johnston, C., Wald, A., Zhu, J., Corey, L., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.118 · Cited by 55
Zhong, G., Brunham, R. C., de la Maza, L. M., Darville, T. L., & Deal, C. D. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.10.075 · Cited by 59
Tissue-Resident T Cells as the Central Paradigm of Chlamydia Immunity
Johnson, R. M., & Brunham, R. C. (2016) · Infection and Immunity · doi:10.1128/iai.01378-15 · Cited by 56
Chlamydia Spreading from the Genital Tract to the Gastrointestinal Tract – A Two-Hit Hypothesis
Zhong, G. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.12.002 · Cited by 58
Chemokines: Critical Regulators of Memory T Cell Development, Maintenance, and Function
Rahimi, R. A., & Luster, A. D. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.02.002 · Cited by 61
“3) (Glennie et al., 2015; Stary et al., 2015).”
Miguel, R. D. V., Calla, N. E. Q., Pavelko, S. D., & Cherpes, T. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162445 · Cited by 54
Tissue-resident memory T cells mediate mucosal immunity to recurrent urinary tract infection
Rousseau, M., Mariano, L. L., Canton, T., & Ingersoll, M. A. (2023) · Science Immunology · doi:10.1126/sciimmunol.abn4332 · Cited by 58
Optimal protection against Salmonella infection requires noncirculating memory
Benoun, J. M., Peres, N. G., Wang, N., Pham, O. H., Rudisill, V. L., Fogassy, Z. N., Whitney, P. G., Fernandez-Ruiz, D., Gebhardt, T., Pham, Q.-M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808339115 · Cited by 55
The role of engineered materials in mucosal vaccination strategies
Eshaghi, B., Schudel, A., Sadeghi, I., Chen, Z., Lee, A. H., Kanelli, M., Tierney, F., Han, J., Ingalls, B., Francis, D. M., et al. (2023) · Nature Reviews Materials · doi:10.1038/s41578-023-00625-2 · Cited by 56
“However, subcutaneous immunization provoked neither a tolerogenic response nor protection, even when combined with adjuvant 161 .”
Self-citationTomar, J., Patil, H. P., Bracho, G. G., Tonnis, W. F., Frijlink, H. W., Petrovsky, N., Rita Vanbever, A., Huckriede, A. L. W., & Hinrichs, W. L. J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.006 · Cited by 51
“This is consistent with previous studies, which showed that mucosal administration of an antigen is necessary for the generation of local T cell responses[47,49,50].”
ResultImpact of the gut microbiota on immune checkpoint inhibitor-associated toxicities
Pezo, R. C., Wong, M., & Martin, A. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819870911 · Cited by 55
Hoffmann, C., Noël, F., Grandclaudon, M., Massenet-Regad, L., Michea, P., Sirven, P., Faucheux, L., Surun, A., Lantz, O. J., Bohec, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29516-w · Cited by 68
Development and Function of Protective and Pathologic Memory CD4 T Cells
Jaigirdar, S. A., & MacLeod, M. K. L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00456 · Cited by 60
Immunology‐Guided Biomaterial Design for Mucosal Cancer Vaccines
Ferber, S., Gonzalez, R. J., Cryer, A. M., von Andrian, U. H., & Artzi, N. (2019) · Advanced Materials · doi:10.1002/adma.201903847 · Cited by 50
Hirahara, K., Kokubo, K., Aoki, A., Kiuchi, M., & Nakayama, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.616309 · Cited by 53
Blakney, A. K., McKay, P. F., Christensen, D., Yus, B. I., Aldon, Y., Follmann, F., & Shattock, R. J. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.043 · Cited by 48
“Recent evidence suggests that an effective vaccine may require the induction of memory T- [3] and/or B cells [4], provide protection against multiple serovars, and be scalable and affordable for inclusive distribution to low and middle income”
BackgroundCarpenter, S. M., Nunes-Alves, C., Booty, M. G., Way, S. S., & Behar, S. M. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005380 · Cited by 48
“Although some argue that generating central memory T cells should be the goal of vaccination against Mtb [73,74], we and others argue that generating resident effector memory cells may be more important [3,75–77], as CD8 T cells residing at the site of infection may be poised to initiate an earlier response.”
Khan, S., Woodruff, E. M., Trapečar, M., Fontaine, K. A., Ezaki, A., Borbet, T. C., Ott, M., & Sanjabi, S. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20161289 · Cited by 48
“The FRT must induce tolerance against commensals and semen antigens and also provide protection against harmful pathogens (Black et al., 2000; Moldenhauer et al., 2009; Marks et al., 2010; Ochiel et al., 2010; Kumamoto and Iwasaki, 2012; Stary et al., 2015).”
BackgroundWoodhall, S., Wills, G., Horner, P., Craig, R., Mindell, J., Murphy, G., McClure, M., Soldan, K., Nardone, A., & Johnson, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0152810 · Cited by 44
Vanić, Ž., Jøraholmen, M. W., & Škalko‐Basnet, N. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113855 · Cited by 53
Li, W., Li, Y., Li, J., Meng, J., Jiang, Z., Chen, Y., Wen, Y., Liu, S., Cheng, X., Mi, S., et al. (2024) · Advanced Science · doi:10.1002/advs.202309770 · Cited by 62
Qu, Y., Frazer, L. C., O’Connell, C. M., Tarantal, A. F., Andrews, C. W., O’Connor, S. L., Russell, A. N., Sullivan, J. E., Poston, T. B., Vallejo, A. N., et al. (2015) · Infection and Immunity · doi:10.1128/iai.00841-15 · Cited by 46
“Genital tract-resident memory CD4 T cells are protective in both the murine herpes model and the murine chlamydial model of infection (33, 38).”
BackgroundNanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis
Gadde, S., & Rayner, K. J. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307481 · Cited by 44
Metadata
- Authors
- Stary, G., Olive, A., Radovic-Moreno, A. F., Gondek, D., Alvarez, D., Basto, P. A., Perro, M., Vrbanac, V. D., Tager, A. M., Shi, J., Yethon, J. A., Farokhzad, O. C., Langer, R., Starnbach, M. N., & von Andrian, U. H.
- Affiliations
- Harvard University (US)
- Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA.
- Division of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA.
- Harvard–MIT Division of Health Sciences and Technology (US)
- Brigham and Women's Hospital (US)
- Sanofi Pasteur, Cambridge, MA 02139, USA.
- Corresponding author
- Stary, Georg
- Olive, Andrew
- ORCID
- Venue
- Science
- Published
- 2015-06-19
- Volume
- 348
- Issue
- 6241
- Pages
- aaa8205-aaa8205
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4605428
- OpenAlex
- W1581039134
- Cited by
- 379
- References
- 67
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 31 · 2023: 31 · 2022: 22 · 2021: 34 · 2020: 42 · 2019: 45 · 2018: 44 · 2017: 47 · 2016: 38 · 2015: 9
- FWCI
- 38.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- PMC
- Funders
- NIH (AI078897, AI069259, AI095261, AI111595, U54-CA119349, U54-CA151884, R37-EB000244, R01-EB015419-01, R00 CA160350, T32 HL066987, P30-AI060354, R01 AI062827, R01 AI39558, U19 AI113187)
- MGH
- MIT
- Harvard University
- arvard Innovation Award from Sanofi Pasteur
- David Koch Prostate Cancer Foundation
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- Chlamydia trachomatis, mucosal vaccines, regulatory T cells, tissue-resident memory T cells, genital tract infection, humanized mice, vaccine adjuvants
- MeSH terms
- Adjuvants, Immunologic, Animals, Bacterial Vaccines, Chlamydia Infections, Chlamydia trachomatis, Dendritic Cells, Female, Immunologic Memory, Mice, Inbred BALB C, Mice, Inbred C57BL, Mucous Membrane, Ultraviolet Rays, Uterus, Vaccination, Vaccines, Inactivated, Antigens, CD, T-Lymphocyte Subsets, CD8-Positive T-Lymphocytes, Th1 Cells, CD11 Antigens, Integrin alpha Chains, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.